1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea

C87H102F6N20O4 — CID 159538796

IUPAC1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea
SMILESCN1CCN(Cc2cc(NC(=O)Nc3ccc(-c4cc(C(C)(C)C)nc5c4cnn5C)cc3)cc(C(F)(F)F)c2)CC1.CN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4cc(C(C)(C)C)nc5c4cnn5C)cc3)cc2C(F)(F)F)CC1.Cn1ncc2c(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cc(C(C)(C)C)nc21
InChIInChI=1S/2C31H36F3N7O.C25H30N6O2/c1-30(2,3)27-17-24(25-18-35-40(5)28(25)38-27)20-6-9-22(10-7-20)36-29(42)37-23-11-8-21(26(16-23)31(32,33)34)19-41-14-12-39(4)13-15-41;1-30(2,3)27-17-25(26-18-35-40(5)28(26)38-27)21-6-8-23(9-7-21)36-29(42)37-24-15-20(14-22(16-24)31(32,33)34)19-41-12-10-39(4)11-13-41;1-24(2,3)19-12-17(18-14-26-31(7)22(18)28-19)15-8-10-16(11-9-15)27-23(32)29-21-13-20(33-30-21)25(4,5)6/h6-11,16-18H,12-15,19H2,1-5H3,(H2,36,37,42);6-9,14-18H,10-13,19H2,1-5H3,(H2,36,37,42);8-14H,1-7H3,(H2,27,29,30,32)
InChIKeyMDXVTWKGKKUJTF-UHFFFAOYSA-N
MW1605.90 g/mol
LogP18.55
Rot. Bonds13

About 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea

1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea (PubChem CID 159538796) has the molecular formula C87H102F6N20O4 and a molecular weight of 1605.90 g/mol. Its IUPAC name is 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea.

Molecular Properties

Compound Name1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea
PubChem CID159538796
Molecular FormulaC87H102F6N20O4
Molecular Weight1605.90 g/mol
Exact Mass1604.83
IUPAC Name1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea
SMILESCN1CCN(Cc2cc(NC(=O)Nc3ccc(-c4cc(C(C)(C)C)nc5c4cnn5C)cc3)cc(C(F)(F)F)c2)CC1.CN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4cc(C(C)(C)C)nc5c4cnn5C)cc3)cc2C(F)(F)F)CC1.Cn1ncc2c(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cc(C(C)(C)C)nc21
InChIInChI=1S/2C31H36F3N7O.C25H30N6O2/c1-30(2,3)27-17-24(25-18-35-40(5)28(25)38-27)20-6-9-22(10-7-20)36-29(42)37-23-11-8-21(26(16-23)31(32,33)34)19-41-14-12-39(4)13-15-41;1-30(2,3)27-17-25(26-18-35-40(5)28(26)38-27)21-6-8-23(9-7-21)36-29(42)37-24-15-20(14-22(16-24)31(32,33)34)19-41-12-10-39(4)11-13-41;1-24(2,3)19-12-17(18-14-26-31(7)22(18)28-19)15-8-10-16(11-9-15)27-23(32)29-21-13-20(33-30-21)25(4,5)6/h6-11,16-18H,12-15,19H2,1-5H3,(H2,36,37,42);6-9,14-18H,10-13,19H2,1-5H3,(H2,36,37,42);8-14H,1-7H3,(H2,27,29,30,32)
InChIKeyMDXVTWKGKKUJTF-UHFFFAOYSA-N
XLogP18.55
TPSA254.51 Ų
H-Bond Donors6
H-Bond Acceptors18
Rotatable Bonds13
Heavy Atoms117
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001605.90
LogP ≤ 518.55
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1018

Analyze 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea?
The IUPAC name of 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea (CID 159538796) is 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea.
What is the SMILES notation for 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea?
The canonical SMILES for 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea is CN1CCN(Cc2cc(NC(=O)Nc3ccc(-c4cc(C(C)(C)C)nc5c4cnn5C)cc3)cc(C(F)(F)F)c2)CC1.CN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4cc(C(C)(C)C)nc5c4cnn5C)cc3)cc2C(F)(F)F)CC1.Cn1ncc2c(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cc(C(C)(C)C)nc21.
What is the InChIKey of 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea?
The InChIKey is MDXVTWKGKKUJTF-UHFFFAOYSA-N. The full InChI is InChI=1S/2C31H36F3N7O.C25H30N6O2/c1-30(2,3)27-17-24(25-18-35-40(5)28(25)38-27)20-6-9-22(10-7-20)36-29(42)37-23-11-8-21(26(16-23)31(32,33)34)19-41-14-12-39(4)13-15-41;1-30(2,3)27-17-25(26-18-35-40(5)28(26)38-27)21-6-8-23(9-7-21)36-29(42)37-24-15-20(14-22(16-24)31(32,33)34)19-41-12-10-39(4)11-13-41;1-24(2,3)19-12-17(18-14-26-31(7)22(18)28-19)15-8-10-16(11-9-15)27-23(32)29-21-13-20(33-30-21)25(4,5)6/h6-11,16-18H,12-15,19H2,1-5H3,(H2,36,37,42);6-9,14-18H,10-13,19H2,1-5H3,(H2,36,37,42);8-14H,1-7H3,(H2,27,29,30,32).
What are the key properties of 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea?
1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea has a molecular weight of 1605.90 g/mol, XLogP of 18.55, 13 rotatable bonds, 6 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]urea;1-[4-(6-tert-butyl-1-methylpyrazolo[5,4-b]pyridin-4-yl)phenyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea is sourced from PubChem (CID 159538796), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).